Your browser doesn't support javascript.
loading
Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
Koskimäki, Fredrika; Bernard, Jacqueline; Yong, Jeong; Arndt, Nancy; Carroll, Timothy; Lee, Seon-Kyu; Reder, Anthony T; Javed, Adil.
Afiliação
  • Koskimäki F; Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.
  • Bernard J; Department of Neurology, Oregon Health Science University, Portland, Oregon, United States of America.
  • Yong J; Northwestern University, Biomedical Engineering, Chicago, Illinois, United States of America.
  • Arndt N; Department of Neurology, The University of Chicago, Chicago, Illinois, United States of America.
  • Carroll T; Department of Radiology, The University of Chicago, Chicago, Illinois, United States of America.
  • Lee SK; Department of Radiology, The University of Chicago, Chicago, Illinois, United States of America.
  • Reder AT; Department of Neurology, The University of Chicago, Chicago, Illinois, United States of America.
  • Javed A; Department of Neurology, The University of Chicago, Chicago, Illinois, United States of America.
PLoS One ; 13(12): e0209326, 2018.
Article em En | MEDLINE | ID: mdl-30576361
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substância Cinzenta / Natalizumab / Esclerose Múltipla Tipo de estudo: Observational_studies Idioma: En Revista: PLoS One Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substância Cinzenta / Natalizumab / Esclerose Múltipla Tipo de estudo: Observational_studies Idioma: En Revista: PLoS One Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Finlândia